Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.

[1]  A. Del Maschio,et al.  T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation. , 2012, Blood.

[2]  Adrian P Gee,et al.  Inducible apoptosis as a safety switch for adoptive cell therapy. , 2011, The New England journal of medicine.

[3]  C. Bordignon,et al.  IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors. , 2011, Blood.

[4]  E. Hauben,et al.  Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. , 2010, Blood.

[5]  D. Jain,et al.  Central Memory CD8+ T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia1 , 2009, The Journal of Immunology.

[6]  P. Muranski,et al.  Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells , 2009, Nature Medicine.

[7]  A. Ganser,et al.  Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. , 2009, The Lancet. Oncology.

[8]  T. Nagasawa,et al.  IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. , 2009, Blood.

[9]  S. Stevanović,et al.  CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT , 2009, Bone Marrow Transplantation.

[10]  H. Kolb.  Graft-versus-leukemia effects of transplantation and donor lymphocytes. , 2008, Blood.

[11]  Mike Gough,et al.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. , 2008, The Journal of clinical investigation.

[12]  A. Winoto,et al.  Apoptosis during negative selection of autoreactive thymocytes. , 2007, Current opinion in immunology.

[13]  D. Douek,et al.  Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia. , 2007, Blood.

[14]  C. Bordignon,et al.  Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation. , 2007, Blood.

[15]  C. Bordignon,et al.  The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. , 2007, Blood.

[16]  S. Kornblau,et al.  Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes. , 2007, Experimental hematology.

[17]  T. D. de Gruijl,et al.  Leukemia-Specific T-Cell Reactivity Induced by Leukemic Dendritic Cells Is Augmented by 4-1BB Targeting , 2007, Clinical Cancer Research.

[18]  H. Heslop,et al.  Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). , 2006, Blood.

[19]  M. Introna,et al.  Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells. , 2006, Experimental hematology.

[20]  F. Locatelli,et al.  Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction. , 2006, Cancer research.

[21]  C. Bordignon,et al.  Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. , 2005, Blood.

[22]  H. Döhner,et al.  Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens , 2005, Cancer Immunology, Immunotherapy.

[23]  P. Circosta,et al.  Leukemia-Derived Immature Dendritic Cells Differentiate into Functionally Competent Mature Dendritic Cells That Efficiently Stimulate T Cell Responses1 , 2004, The Journal of Immunology.

[24]  U. Scherf,et al.  Induced Dendritic Cell Differentiation of Chronic Myeloid Leukemia Blasts Is Associated with Down-Regulation of BCR-ABL1 , 2003, The Journal of Immunology.

[25]  G. Ossenkoppele,et al.  Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia , 2003, Leukemia.

[26]  J. Goldman,et al.  Human cytotoxic T lymphocytes specific for Wilms’ tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients , 2003, Transplantation.

[27]  Antonio Lanzavecchia,et al.  T cell fitness determined by signal strength , 2003, Nature Immunology.

[28]  Els Goulmy,et al.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Klatzmann,et al.  Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease. , 2002, Blood.

[30]  J. Falkenburg,et al.  An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice. , 2002, Blood.

[31]  P. Chevallier,et al.  Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. , 2002, Cancer research.

[32]  F. Appelbaum,et al.  Haematopoietic cell transplantation as immunotherapy , 2001, Nature.

[33]  J. Falkenburg,et al.  Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice. , 2001, Experimental Hematology.

[34]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[35]  R. Foà,et al.  CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. , 1999, Blood.

[36]  B. Czerniecki,et al.  Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. , 1999, Journal of immunology.

[37]  M. Davis,et al.  A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. , 1999, Cancer research.

[38]  Y. Sonoda,et al.  Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. , 1997, Blood.

[39]  R. Reibke,et al.  Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential. , 2010, Cellular immunology.

[40]  D. Mueller.  Mechanisms maintaining peripheral tolerance , 2010, Nature Immunology.

[41]  เอกรัฐ รัฐฤทธิ์ธำรง.  Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation , 2009 .

[42]  G. Schuurhuis,et al.  Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia , 2003, Cancer Immunology, Immunotherapy.